Navigation Links
Cambrex Acquires IEP GmbH
Date:3/22/2010

EAST RUTHERFORD, N.J., March 22 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) announced it has acquired IEP GmbH (“IEP”), a privately held company that is a leader in the field of industrial biocatalysis.  IEP is located in Wiesbaden, Germany and offers cost effective customized biocatalytic process development and sales of enzymes to the pharmaceutical industry, with the ability to utilize its tool box of over 100 proprietary biocatalytic enzymes.  IEP “bioreduction” technologies have been successfully used in numerous commercialized processes.

“In combination with our existing chiral chemistry business, the acquisition of IEP will result in Cambrex being able to offer a broad biocatalysis platform to the pharmaceutical industry.  We are very excited about the future growth of this business, as IEP has demonstrated the introduction of a “green” biocatalytic step in chemical synthesis that can provide significant benefits resulting in the cost efficient, commercial scale production of enantiomerically pure chemical products and intermediates.  IEP has assembled, under the leadership of Dr. Antje Gupta, a strong group of highly skilled scientists and built a successful business based on its proprietary technology and intellectual property.  We are looking forward to working with the IEP team to expand their business development efforts through the existing Cambrex channels to market,” commented Steven Klosk, President & CEO of Cambrex Corporation.

The business will be renamed Cambrex IEP and will remain in Wiesbaden, Germany.  For more information on IEP, please visit www.biocatalysis.com.

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule active pharmaceutical ingredients (“APIs”), advanced intermediates and other products for branded and generic pharmaceuticals.  The Company currently employs approximately 850 people worldwide.  For more information, please visit www.cambrex.com.

SOURCE Cambrex Corporation

Back to top

RELATED LINKS
http://www.cambrex.com

'/>"/>

SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
2. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
3. Cambrex Reports Third Quarter 2009 Results
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
6. U.S. Preventive Medicine Acquires Specialty Disease Management
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2017)... 1, 2017 Michael Penna , President ... highlights opportunities for growth in his response to the ... Equity is seeking a buyer for eMDs. Penna,s company, ... healthcare solutions Value Added Reseller and national leader in ... "As the healthcare market continues to dictate ...
(Date:8/29/2017)... Va. , Aug. 29, 2017 ivWatch, LLC, the ... peripheral IV infiltrations, announced it has been awarded an Innovative Technology ... company in the country. ... continuous monitoring device to aid in the early detection of peripheral ... The Innovative ...
(Date:8/25/2017)...  Innovation Zed ( www.innovationzed.com ), an Irish medtech company, today announced ... Yorkshire and Bassetlaw, England . ... patients as part of a national NHS Test Bed programme exploring new ... Innovation Zed ... InsulCheck Connect, a snap-on accessory for disposable insulin pen users, automatically ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... of providing a voice for people who have kidney disease. The theme “Describe ... to share their stories. Entrants needed to meet only one qualification— to ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... roster of exhibitors at the East-coast edition of MarTech: The Marketing Tech Conference ... will bring together more than 40 speakers — representing such thought-leading companies ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... gather for the National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New ... It is also when Athletic Trainers are acknowledged by their peers with accolades ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare and Medicaid Services ... will transition to using only Worksheet S-10 to distribute Disproportionate Share Hospital (DSH) Uncompensated ... 60-minute complimentary webinars on October 17, 2017 at 2 P.M. EST and ...
(Date:9/20/2017)... ... ... Trials I Face to Receive God’s Grace”: a mesmerizing take on one man’s ... one’s life through God. “The Trials I Face to Receive God’s Grace” is the ... a love for writing. Green feels that expressing his feelings through prayer will present ...
Breaking Medicine News(10 mins):